Kraig Biocraft Laboratories, Inc financial data

Symbol
KBLB on OTC
Location
2723 South State Street, Suite 150, Ann Arbor, Michigan
State of incorporation
Wyoming
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.4 % -36.3%
Quick Ratio 0.08 %
Debt-to-equity -163 % +28.2%
Return On Equity 55.4 % -37.7%
Return On Assets -88.2 % -25.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.04B shares +0.48%
Entity Public Float 42.3M USD -15.4%
Weighted Average Number of Shares Outstanding, Basic 1.04B shares +0.61%
Weighted Average Number of Shares Outstanding, Diluted 1.04B shares +0.61%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 198K USD -9.08%
General and Administrative Expense 1.41M USD +70.9%
Operating Income (Loss) -2.58M USD -25%
Nonoperating Income (Expense) -394K USD +69.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.97M USD +11.6%
Net Income (Loss) Attributable to Parent -2.97M USD +11.6%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.05M USD
Inventory, Net 6.88K USD +4.62%
Assets, Current 2.06M USD -42.2%
Property, Plant and Equipment, Net 59.9K USD -26.3%
Operating Lease, Right-of-Use Asset 114K USD +143%
Assets 2.77M USD -33.4%
Accrued Liabilities, Current 191K USD
Liabilities, Current 8.96M USD +9.33%
Operating Lease, Liability, Noncurrent 58K USD +586%
Liabilities 9.01M USD +9.92%
Accumulated Other Comprehensive Income (Loss), Net of Tax 13K USD
Retained Earnings (Accumulated Deficit) -50.2M USD -6.29%
Stockholders' Equity Attributable to Parent -6.24M USD -54.6%
Liabilities and Equity 2.77M USD -33.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -490K USD -23.8%
Net Cash Provided by (Used in) Financing Activities -15K USD 0%
Net Cash Provided by (Used in) Investing Activities -6.4K USD -27.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -505K USD -22.9%
Deferred Tax Assets, Valuation Allowance 5.34M USD +9.32%
Operating Lease, Liability 115K USD +141%
Depreciation 27.7K USD +1.69%
Payments to Acquire Property, Plant, and Equipment 6.4K USD +27.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.97M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid 127K USD +145%
Operating Lease, Liability, Current 56.7K USD +44.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.1K USD +51.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 51.7K USD +78.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.8K USD +198%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.32K USD -15.3%
Deferred Tax Assets, Operating Loss Carryforwards 5.34M USD +9.32%
Preferred Stock, Shares Issued 0 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.71K USD +16.4%
Operating Lease, Payments 13.4K USD
Additional Paid in Capital 11.3M USD +4.83%
Preferred Stock, Shares Outstanding 0 shares